Capricor Therapeutics (CAPR) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of$0.32. This compares to loss of $0.29 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -9.38$0.11 per share when it actually produced a loss of $0.31, delivering a surprise of -181.82%.Over the last four quarters, th ...